Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.310
+0.050 (3.97%)
At close: Jun 27, 2025, 4:00 PM
1.400
+0.090 (6.87%)
After-hours: Jun 27, 2025, 6:28 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $371.11 million as of June 27, 2025. Its market cap has decreased by -39.49% in one year.
Market Cap
371.11M
Enterprise Value
10.84M
1-Year Change
-39.49%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $371.11M, a decrease of -80.03%. That is a compound annual growth rate of -33.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 371.11M | -47.71% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| Novo Nordisk | 331.06B |
| AbbVie | 322.03B |
| UnitedHealth Group | 280.41B |
| Abbott Laboratories | 233.80B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |